Anaesthesia, critical care & pain medicine · 2026
Withholding Pre-emptive Antibiotics After Pancreaticoduodenectomy in Patients with Biliary Colonization: A Multicenter Propensity Score-Matched Cohort Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ilardo Antoine, Leone Marc, Fara Regis, Nafati Cyril, Bisbal Magali, Velly Lionel, Chow-Chine Laurent, Sannini Antoine, Gonzalez Frédéric, de Guibert Jean Manuel, Barbey Julien, Birbaum David, Chopinet Sophie, Faucher Marion, Mokart Mona, Garnier Jonathan, Mokart Djamel
Аннотация
BACKGROUND: Pre-emptive antibiotic therapy is frequently prescribed after pancreaticoduodenectomy when intraoperative bile cultures are positive, despite the absence of clinical infection. Evidence supporting this practice remains limited. We assessed the association between withholding pre-emptive antibiotics and postoperative outcomes in patients with biliary colonization.
METHODS: This multicenter retrospective cohort study included 301 consecutive adults undergoing pancreaticoduodenectomy with positive intraoperative bile cultures in four French tertiary centers between January 2014 and December 2024. Overall, 89 patients received PE-ATB, and 212 did not. Propensity score matching at a 1:2 ratio yielded 138 patients, including 46 treated patients and 92 controls. The primary outcome was 5-year overall survival. Secondary postoperative outcomes were examined using prespecified exploratory non-inferiority margins.
RESULTS: Preoperative biliary stenting independently predicted PE-ATB use (odds ratio, 4.11; 95% confidence interval, 1.26-13.40;P = 0.019). In the matched cohort, withholding PE-ATB was compatible with the non-inferiority margin for intra-abdominal abscess, pancreatic fistula, transfusion requirements, and antibiotic duration. Overall postoperative infection did not differ significantly between groups (odds ratio, 1.42; 95% confidence interval, 0.66-3.07; P = 0.376). Five-year mortality was higher in the group without PE-ATB in the matched cohort (hazard ratio, 2.02; 95% confidence interval, 1.01-4.04; P = 0.048), whereas no survival difference was observed in the overall unmatched cohort.
CONCLUSIONS: Withholding PE-ATB was not associated with worse early postoperative outcomes and was associated with reduced antibiotic exposure. The survival difference observed only after matching should be considered cautiously and may reflect residual confounding. Prospective randomized trials are needed.
METHODS: This multicenter retrospective cohort study included 301 consecutive adults undergoing pancreaticoduodenectomy with positive intraoperative bile cultures in four French tertiary centers between January 2014 and December 2024. Overall, 89 patients received PE-ATB, and 212 did not. Propensity score matching at a 1:2 ratio yielded 138 patients, including 46 treated patients and 92 controls. The primary outcome was 5-year overall survival. Secondary postoperative outcomes were examined using prespecified exploratory non-inferiority margins.
RESULTS: Preoperative biliary stenting independently predicted PE-ATB use (odds ratio, 4.11; 95% confidence interval, 1.26-13.40;P = 0.019). In the matched cohort, withholding PE-ATB was compatible with the non-inferiority margin for intra-abdominal abscess, pancreatic fistula, transfusion requirements, and antibiotic duration. Overall postoperative infection did not differ significantly between groups (odds ratio, 1.42; 95% confidence interval, 0.66-3.07; P = 0.376). Five-year mortality was higher in the group without PE-ATB in the matched cohort (hazard ratio, 2.02; 95% confidence interval, 1.01-4.04; P = 0.048), whereas no survival difference was observed in the overall unmatched cohort.
CONCLUSIONS: Withholding PE-ATB was not associated with worse early postoperative outcomes and was associated with reduced antibiotic exposure. The survival difference observed only after matching should be considered cautiously and may reflect residual confounding. Prospective randomized trials are needed.